This week at Retraction Watch featured a look at the huge problem of misidentified cell lines, a check-in with a company that retracted a paper as it was about to go public, and Diederik Stapel’s 58th retraction. Here’s what was happening elsewhere:
This week’s Weekend Reads, which appears below, was preempted yesterday by the news that the Office of Research Integrity had issued a finding of misconduct in the long-running case of Anil Potti. The week also featured news about a child psychiatry trial halted for unexplained reasons, and saw the launch of our new weekly column … Continue reading Weekend reads: Elsevier mutiny; babies as co-authors; what to do after rejection
The week at Retraction Watch featured the results of a massive replication study, yet another retraction for Diederik Stapel, and a messy situation at PLOS. Here’s what was happening elsewhere:
This week, we marked the fifth anniversary of Retraction Watch with the announcement of a generous new grant. We also covered the retraction of a slew of papers in a journal plagued by problems. Here’s what was happening elsewhere:
Who has the most retractions? Here’s our unofficial list (see notes on methodology), which we’ll update as more information comes to light: Joachim Boldt (220) See also: Editors-in-chief statement, our coverage Yoshitaka Fujii (172) See also: Final report of investigating committee, our reporting, additional coverage Yoshihiro Sato (124) See also: our coverage Hironobu Ueshima (124) … Continue reading The Retraction Watch Leaderboard
This week at Retraction Watch featured a hotly debated guest post from Leonid Schneider and two ORI findings. Here’s what was happening elsewhere:
Another busy week at Retraction Watch, but there was lots happening elsewhere, too:
Another busy week at Retraction Watch, with Harvard dominating the news about scientific misconduct here and elsewhere. Here’s what else was happening around the web:
Retraction Watch has learned that The Leadership Quarterly, a management journal published by Elsevier, plans to retract five papers by a Florida researcher poised to “rock” the field — but probably not quite in the way a press release intended — whose findings in the articles were questioned by readers. The scholar, Fred O. Walumbwa, … Continue reading Leadership journal to retract five papers from FIU scholar
Alirio Melendez, who has already retracted five papers and was found by one of his former universities to have committed misconduct on more than 20, has three more retractions. Here’s the notice for “Antisense Knockdown of Sphingosine Kinase 1 in Human Macrophages Inhibits C5a Receptor-Dependent Signal Transduction, Ca2+ Signals, Enzyme Release, Cytokine Production, and Chemotaxis,” … Continue reading And then there were eight: Three more retractions for Alirio Melendez, all in the Journal of Immunology